SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Concord Biotech - Quaterly Results

08 Aug 2025 Evaluate
The sales slipped to Rs. 2039.88 millions for the June 2025 quarter as against Rs. 2158.02 millions during the year-ago period.Net profit declined -26.91% to Rs. 425.66 millions from Rs. 582.39 millions.The Operating Profit of the company witnessed a decrease to 750.75 millions from 915.86 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 2039.88 2158.02 -5.47 2039.88 2158.02 -5.47 12000.87 10169.39 18.01
Other Income 136.78 103.08 32.69 136.78 103.08 32.69 444.47 337.80 31.58
PBIDT 750.75 915.86 -18.03 750.75 915.86 -18.03 5507.79 4653.36 18.36
Interest 0.59 2.41 -75.52 0.59 2.41 -75.52 5.29 25.52 -79.27
PBDT 750.16 913.45 -17.88 750.16 913.45 -17.88 5502.50 4627.84 18.90
Depreciation 177.76 131.78 34.89 177.76 131.78 34.89 543.74 535.92 1.46
PBT 572.40 781.67 -26.77 572.40 781.67 -26.77 4958.76 4091.92 21.18
TAX 146.74 199.28 -26.36 146.74 199.28 -26.36 1229.11 1044.62 17.66
Deferred Tax 5.96 5.34 11.61 5.96 5.34 11.61 39.50 46.28 -14.65
PAT 425.66 582.39 -26.91 425.66 582.39 -26.91 3729.65 3047.30 22.39
Equity 104.62 104.62 0.00 104.62 104.62 0.00 104.62 104.62 0.00
PBIDTM(%) 36.80 42.44 -13.28 36.80 42.44 -13.28 45.89 45.76 0.30

Concord Biotech Share Price

1067.95 -13.30 (-1.23%)
20-Apr-2026 12:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1672.50
Dr. Reddys Lab 1236.80
Cipla 1234.00
Zydus Lifesciences 938.50
Lupin 2323.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×